Money Raised in September 2024

In September there was over $14 billion raised by companies in the Biotech and Biopharma Space, this is over double what was raised in August. Hopefully this is a good sign of where the market is headed

Key findings:

??The largest amount of money raised was by LabCorp who raised over $2 billion in Post-IPO Debt

??The largest amount raised by a private company was by Candid Therapeutics who raised $370 million in their series B funding round.

??Over $2.5 billion between Pre-Seed and Series H funding rounds, this is $1 billion higher than last month

2,000,000 Polku Therapeutics (Finland) is carving a new path to a healthy aging brain by developing novel disease-modifying therapies for neurodegenerative disorders.

1,600,000 Aptadir Therapeutics (Italy) is developing a treatment for Myelodysplastic Neoplasms based on the capability of specific RNA therapeutics.

1,438,983 Lucid Genomics (Germany) had a cutting-edge is an AI-powered platform that is designed to revolutionize diagnostics and drug discovery by extracting valuable insights from genomic data, and enabling more accurate development of targeted therapeutic solutions. Their platform leverages advanced machine learning to identify genetic variations with unmatched accuracy, prioritizing both coding and non-coding regions.

178,181 Translation-X (Switzerland) is a spin-off project that develops novel therapeutics for Auatim spectrum disorders.

Unknown MucoLife Therapeutics (Sweden) is revolutionizing the treatment of mucus obstruction in Chronic Obstructive Pulmonary Disorder & Cystic Fibrosis.

Unknown Human Biogenesis (India) is a company that developing a first-of-its-kind semen detection test that can establish pregnancy risk within 15 minutes.

Unknown TippingPoint Biosciences (CA, USA) is an early-stage therapeutic company with a novel drug discovery platform to identify first-in-class drugs aimed at treating diseases related to dysfunctional DNA packaging (chromatin).

30,000,000 Chai Discovery (CA, USA) develops AI models for molecular structure prediction in drug discovery.

26,000,000 Vironexis (CA, USA) is focused on transforming the future of cancer treatment by pioneering AAV-delivered T-cell immunotherapy.

15,000,000 Bambusa Therapeutics (MA, USA) a biotechnology company focused on developing bispecific antibodies for the treatment of immunological and inflammatory (I&I) disorders.

15,000,000 SyntaxBio (IL, USA) develops genetic programming platform that can program cells without the need for consistent external intervention.

6,500,000 CardiaTec (United Kingdom) is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.

5,000,000 AminoChain (NY, USA) focuses on tokenizing stem cells, a form of regenerative therapy, and creating incentives for donors to participate.

5,000,000 Safi Biosolutions (MA, USA) is an early-stage biotech company developing manufactured red blood cell (mRBC) therapies from stem cells.

4,500,000 VerImmune (MD, USA) is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection.

4,000,000 ZipBio (WA, USA) develops next-gen gene therapies using machine learning, protein engineering, and molecular materials.

3,515,233 Tanai Therapeutics (Belgium) are a developer of orally administered therapeutics designed for fat loss while preserving muscle mass.

3,183,829 HDAX Therapeutics (Canada) is a company pioneering next-gen precision therapeutics for diseases stemming from microtubule dysfunction, such as neuropathies and cardiovascular diseases.

1,062,177 NunaBio (United Kingdom) is a privately-owned specialist DNA synthesis and development company, engaged in CRO and CDMO activities. The company has built a solid reputation for its R&D flexibility and innovative approach to complex and challenging projects.

741,219 MicrobiomeOstia Sciences (Canada) is a premier microbiome solutions company that specializes in discovering novel bacterial metabolites with antibacterial, antibiofilm, and immunomodulation activities.

177,328 Abrinca Genomics (Switzerland) have crafted a groundbreaking microbial bioinformatics and data management platform designed to supercharge genomics research. OpenGenomeBrowser combines our state-of-the-art analytics suite with advanced genome data management, empowering microbiologists and bioinformaticians to achieve faster, more accurate insights.

Unknown Remedium Bio (MA, USA) is a gene therapy company focused on the development of highly innovative treatments for a broad range of diseases.

120,000,000 Superluminal Medicines (MA, USA) is a generative biological and chemical company that innovates drug discovery and development processes.

68,000,000 Nura Bio (CA, USA) is a clinical-stage biopharmaceutical company focused on developing neuroprotective therapies to treat neurological diseases.

65,000,000 GC Therapeutics (MA, USA) uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.

58,000,000 Constructive Bio (United Kingdom) is a ground-breaking method for creating wholly artificial genomes and rewriting the genetic code of living things.

35,000,000 Radiant Biotherapeutics (Canada) is a preclinical biotechnology company developing an antibody platform to deliver transformative therapies for patients facing life-changing disease.

25,000,000 Brenus Pharma (France) is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance.

21,800,000 Synex Medical (Canada) is dedicated to providing people with accurate information about how their bodies are functioning to make predictive health a reality.

15,300,000 Mindpeak (Germany) develops and distributes AI-based diagnostic software for the detection, quantification, and classification of cancer.

13,354,380 LIfT Biosciences (United Kingdom) is a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy

13,098,280 NanoSyrinx (United Kingdom) is a discovery stage synthetic biology company developing a novel system based around naturally occurring ‘nanosyringes’, to overcome this challenge by delivering therapeutic proteins and peptides direct to the cytosol in a targeted manner.

11,171,499 Sequentia Biotech (Spain) is a leading omics company that offers advanced bioinformatic solutions to transform omics data into clinical, industrial and research applications.

10,250,000 Eradivir (IN, USA) is a biotech company that aims to develop a non-immunological targeting agent for use against the virus that causes COVID-19.

10,000,000 Enzymit (Israel) is setting a new paradigm for bioproduction through the design and creation of novel enzymes that streamline production processes, reduce costs and promote sustainability.

5,000,000 Ahammune Biosciences (India) is an innovation-led drug discovery company started in 2016 which focuses on developing new treatment options for immune mediated diseases of the skin. Our current program is on the depigmenting disorder, Vitiligo.

3,600,000 Syantra (Canada) is a privately held, precision biotechnology company that's changing the way cancer is detected and treated.

Unknown Base Therapeutics (China) is a technology-driven innovative enterprise focusing on foundational innovations in gene editing.

Unknown Hegeia Biotechnology (China) is a company that focused on the research and development of siRNA, tiny nucleic acid attached delivery medicines.

Unknown Enjosim (China) specializes in the R&D, manufacturing, and sales of self-delivery systems, particularly those for biomacromolecule pharmaceuticals. It currently sells a variety of high-precision pen injectors designed for biologics such as insulin, growth hormone, and GLP-1.

370,000,000 Candid Therapeutics (CA, USA) is a biotechnology company that focuses on the treatment of a range of immunological conditions.

175,000,000 Aktis Oncology (MA, USA) is a biotechnology company that designs and develops novel class radiopharmaceuticals.

100,000,000 Vicebio (United Kingdom) is committed to employing the Molecular Clamp Technology to create vaccines against next-generation respiratory viruses.

67,000,000 OrsoBio (CA, USA) is developing novel approaches to treat patients with severe metabolic disorders, including obesity, diabetes, severe dyslipidemias, NASH, and more.

52,000,000 Genespire (Italy) is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.

50,000,000 858 Therapeutics (CA, USA) is a clinical-stage drug discovery and biotechnology company developing a portfolio of small molecule drugs that act on novel therapeutic targets in oncology and immunology.

42,000,000 Nomic (Canada) is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. They are building the nELISA, a next-generation ELISA platform for measuring proteins at scale and at high throughput.

30,000,000 PictorLabs, Inc. (CA, USA) is a digital pathology company developing an AI-powered virtual staining platform to revolutionize histopathology and accelerate clinical research with the goal of improving patient outcomes.

21,000,000 Feldan (Canada) is a biopharmaceutical company that specialized in the development of innovative treatments based on intracellular delivery. They have the Feldan Shuttle, a unique peptide-based technology that provides access to intracellular targets beyond the reach of existing drugs, opening unprecedented opportunities to treat a wide range of diseases, notably respiratory and skin diseases.

16,408,183 Epsilogen (United Kingdom) is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.

15,000,000 Amprion (CA, USA) is a global leader advancing precision medicine for neurodegenerative disorders through seed amplification testing.

12,000,000 PhoreMost (United Kingdom) has developed a next-generation phenotypic screening platform called SITESEEKER? which can discern the best new targets for future therapies and, crucially, how to drug them. This has the potential to significantly increase the diversity of novel therapeutics for cancers and other disease of unmet need.

325,000,000 ArsenalBio (CA, USA) is a programmable cell therapy company that offers CAR T-cell therapies for solid tumors.

42,000,000 Redcliffe Labs (India) has built a comprehensive portfolio approach both with routine and specialized test menus with advanced testing labs all over India. They cater to all diagnostic needs, thereby contributing to the health needs of millions of patients.

38,000,000 Arzeda (WA, USA) is a protein design company that creates and manufactures proteins and enzymes for pharmaceuticals and industrial chemicals.

11,000,000 ImmunOs Therapeutics AG (Switzerland) is developing the next generation of immunotherapies that have a role in the innate immune system for cancer and autoimmune diseases.? The company is developing therapies that not only have direct anti-tumor effects but also remodel the tumor microenvironment to enhance the efficacy of existing immunotherapies.

191,000,000 eGenesis (MA, USA) is a biotechnology company committed to using its multiplex gene editing and genome engineering platform to transform solid organ and therapeutic cell transplantation for the treatment of serious diseases.

90,000,000 Circle Pharma (CA, USA) is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.

65,000,000 ONL Therapeutics (MI, USA) is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

57,000,000 Inflammatix (CA, USA) develops rapid immune system diagnostics to improve patient care and public health.

100,000,000 F2G (United Kingdom) is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening invasive fungal infections.

166,710,382 Austrian Academy of Sciences (OeAW) (Austria) is further expanding its focus on life sciences by opening an institute for Biomedical Artificial Intelligence (AI) based on a € 150 million funding from the German non-profit Boehringer Ingelheim Foundation (BIS).

29,000,000 Basilea (Switzerland) is a commercial-stage biopharmaceutical company, committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections.

Up to 27,000,000 Phare Bio (USA) is a social venture using artificial intelligence (AI) to develop novel classes of antibiotics in partnership with Jim Collins' lab at MIT and Harvard’s Wyss Institute.

25,000,000 Cellino (MA, USA) is building a scalable, automated biomanufacturing system for potentially curative personalized cell therapies.

22,000,000 C?N Diagnostics’ (MO, USA) vision is to bring Clarity Through Innovation?. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent or stop the progression of human neurological disorders. Diagnostic efforts revolve around bringing accurate, widely accessible, and cost-effective blood tests to the clinic for the betterment of patient care and brain health monitoring.

22,000,000 MediciNova (CA, USA) is a? biopharmaceutical company that acquires and develops novel, small-molecule therapeutics.

12,000,000 MayoClinic (MN, USA) is a nonprofit medical practice and medical research group focused on integrated health care, education, and research.

5,000,000 EnClear Therapies (MA, USA) is a biotechnology company developing device-based therapies for the treatment of neurodegenerative disease

4,970,000 Enalare Therapeutics (FL, USA) is a clinical stage? biopharmaceutical company dedicated to developing novel therapies.

4,000,000 AcuraStem (CA, USA) harnesses human, patient-specific in vitro cell models and assays to develop cures and improve diagnoses in disorders of the CNS.

4,000,000 Tiziana Life Sciences (United Kingdom) is a clinical stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and neuroinflammatory. Their clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Alzheimer’s, and ALS.

3,800,000 Neurona (CA, USA) is a clinical-stage biotherapeutics company developing regenerative cell therapies that permanently integrate into neural circuits, replace affected cells, and rebalance dysregulated electrical activity to repair the nervous system

3,700,000 Oklahoma Medical Research Foundation (OK, USA) is a foundation for Alzheimer's, heart disease, cancer and other devastating illnesses.

3,000,000 Neurexis (CO, USA) is developing an optimized peptide with demonstrated efficacy and safety in small and large animal models of global cerebral ischemia.

2,700,000 Cenna Biosciences (CA, USA) develops disease modifying drugs for Alzheimer's disease using a proprietary novel mechanism.

Grant (€2.5 mill) and Private Equity (€10 mill) total $11,113,000 BioSourcing (Belgium) is developing a New Generation of Biotherapeutics, in particular Monoclonal Antibodies for Global Unmet Medical Needs

2,200,000 Sinopia Biosciences (CA, USA) enables data-driven drug discovery by means of multi-omics data, machine learning, network analyses, and disease models.

2,000,000 TransCode Therapeutics (MA, USA) is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.

2,000,000 CytoAgents (PA, USA) is a biotechnology company focused on the the treatment of COVID-19, Influenza, and other viral infectious diseases.

1,930,000 AmideBio (CO, USA) discovers peptide therapeutics for metabolic disease. The company uses advanced in-silico techniques to intelligently design novel peptides, its proprietary technology (BioPure? process) to efficiently generate them and testing schemes to quickly assess their biological activity.

1,894,742 Novigenix (Switzerland) is a precision medicine company specialized in ImmunoTranscriptomic solutions for early detection of disease, development of novel therapeutics, and drug target discovery. The Novigenix proprietary LITOSeek? platform is an AI-enabled RNA analytic platform optimized for mapping the response of the immune system to onset and progression of disease.

1,532,563 Mabylon AG (Switzerland) is a biotechnology company harnessing the therapeutic potential of naturally occurring human antibodies to treat allergies, neurodegenerative diseases, and inflammation.

1,000,000 Noetik (CA, USA) is an AI-native biotechnology company. Their mission is to leverage advanced machine learning methods to discover and develop cancer immunotherapies.

666,642 Industrial Plankton (Canada) manufactures algal bioreactors with application in research and aquaculture.

652,312 Epitopea (MA, USA) is a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies for use in hard-to-treat cancers by targeting a new class of untapped antigens that are broadly shared across multiple patients with the same tumor type.

500,000 iLoF (United Kingdom) is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery and development.

350,000 Resolute Science (CA, USA) is a preclinical-stage biotechnology company developing a novel class of pan-cancer therapeutics for the treatment of aggressive and hard-to-treat solid tumors.

300,000 La Jolla Institute for Allergy & Immunology (CA, USA) is a biomedical research institute helps in understanding of immune system disease.

300,000 J. Craig Venter Institute (MD, USA) is a non-profit organization engaged in the research of genomics.

300,000 Daxor Corporation (NY, USA) is the global leader in blood volume measurement technology focused on blood volume testing innovation. They developed and market the BVA-100, the first diagnostic blood test cleared by the FDA.

250,000 ImmunoScape (Singapore) offers a tech platform that allows profiling and characterization of the human immune response.

250,000 Beken Bio (CA, USA) develop liquid biopsies for early cancer detection that target novel extracellular vesicle (EV) biomarkers in patient blood.

250,000 Palm Therapeutics (CA, USA) is a next-generation therapeutics company to cure cancer at its source.

150,000 Verismo Therapeutics (PA, USA) develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.

Unknown ATCC (VA, USA) is a premier global biological materials and information resource and standards organization and the leading developer and supplier of authenticated cell lines, microorganisms, and associated data for academia, industry, and government.

Unknown Dignify Therapeutics (NC, USA) is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.

Unknown GliaPharm (Switzerland) is a biotechnology company that develops treatments for neurological and psychiatric disorders.

Grant (€2.5 mill) and Private Equity (€10 mill) total $11,113,000 BioSourcing (Belgium) is developing a New Generation of Biotherapeutics, in particular Monoclonal Antibodies for Global Unmet Medical Needs

200,000,000 Serán BioScience (OR, USA) is a leading CDMO providing a comprehensive suite of development, analytical and manufacturing services to pharmaceutical and biotechnology companies.

118,113 Orio Therapeutics (Switzerland) is redefining regeneration by modifying therapeutic proteins to optimize distribution through controlled localization.

8,100,000 Find therapeutics (Canada) design ground-breaking therapies through precision-targeting of membrane receptors to bring hope to people living with autoimmune diseases.

Unknown Alopexx (MA, USA) partners with innovative entrepreneurs to build successful new companies. We will in-license novel therapies or medical devices

55,000,000 Prime Medicine (MA, USA) is a leading biotechnology company dedicated to creating and delivering the next generation of gene editing therapies to patients.

140,000,000 BillionToOne (CA, USA) is a precision diagnostics company that focuses on genetic testing for disease detection.

89,285,615 CaixaResearch Institute (Spain) aspires to improve Europe's healthcare competitiveness by expanding our understanding of immune system.

20,000,000 Panacea Biotec (India) is a research-based health management company involved in research, manufacturing and marketing of high-quality, affordable pharmaceutical, vaccines and herbal products.

117,564 Nexco Analytics (Switzerland) is a bioinformatics services company that offers data analysis services to private customers and public institutions.

Unknown Neovantage Innovation Parks (India) creates a specialized infrastructure platform for pharmaceutical and biotechnology companies.

1,500,000,000 Vaxcyte (CA, USA) focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.

575,000,000 Nuvalent (MA, USA) is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer.

500,300,000 Ionis Pharmaceuticals (CA, USA) specializes in the discovery and development of RNA-targeted drugs.

300,000,000 Ascendis Pharma (CA, USA) built a high-value pipeline that aims to change the clinical treatment paradigms.

275,000,000 Oruka Therapeutics (MA, USA) is advancing innovative biologics to redefine patient care standards in chronic skin diseases.

250,000,000 Biohaven (CT, USA) is a biopharmaceutical company that develops drug candidates targeting neurological diseases.

235,000,000 Summit Therapeutics (United Kingdom) is a clinical-stage drug discovery and development company.

225,000,000 Viridian Therapeutics (MA, USA) is a biotechnology company that offers treatments for patients suffering from diseases.

225,000,000 Centessa Pharmaceuticals (MA, USA) is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process.

201,300,000 Xencor (CA, USA) develops superior monoclonal antibody therapeutics to treat autoimmune disorders, asthma, allergic diseases and cancer.

200,000,000 Relay therapeutics (MA, USA) is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

200,000,000 Wave Life Sciences (MA, USA) is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases

150,150,000 Terns Pharmaceuticals (CA, USA) is a biopharmaceutical company that focuses on discovering therapies that will improve the global disease burden.

67,833,293 Valneva (France) focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

67,500,000 Liquidia Technologies (NC, USA) is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.

40,000,000 MDxHealth (CA, USA) is a molecular diagnostics company that develops epigenetic tests for cancer assessment and personalized treatment of patients.

36,000,000 Atara Biotherapeutics (CA, USA) is an off-the-shelf, allogeneic T-cell immunotherapy company.

27,000,000 Ventyx (CA, USA) is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

15,000,000 Capricor Therapeutics (CA, USA) is a biotechnology company focusing on cell and exosome-based therapeutics.

12,000,000 Cue Biopharma (MA, USA) is a developer of a productive platform for the treatment of cancer and autoimmune disease.

10,111,278 Vicore Pharma (Sweden) is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders.

8,000,000 Fortress Biotech (NY, USA) is a biopharmaceutical company that focuses on acquiring, developing, and commercializing therapeutic products.

7,300,000 Clene Nanomedicine (UT, USA) focuses on the development of unique therapeutics for neurodegenerative diseases.

6,200,000 Vaccinex (NY, USA) is a biotechnology company engaged in the development of novel therapeutic antibodies for neurodegenerative disorders and oncology.

5,580,351 AB Science (France) is a pharmaceutical company specializing in drugs use tyrosine kinase inhibitors.

5,000,000 Pasithea Therapeutics (CA, USA) is a biotechnology company that seeks to solve clinical problems such as mental health.

5,000,000 Synaptogenix (NY, USA) is a clinical-stage biopharmaceutical company that develops novel therapies for neurodegenerative diseases.

4,450,000 Oragenics (FL, USA) is a development-stage company that primarily engages in fighting infectious diseases.

4,000,000 60 Degrees Pharmaceuticals (DC, USA) develops and commercializes new medicines to treat and prevent infectious diseases.

4,000,000 Eyenovia (NY, USA) is a biopharmaceutical company that provides a portfolio of next generation topical eye treatments.

4,000,000 Altamira Therapeutics (Switzerland) develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.

3,702,228 Ondine Biomedical (Canada) develops non-antibiotic, anti-infective therapies for a broad spectrum of bacterial, viral, and fungal infections.

3,470,000 Qualigen Therapeutics, Inc. (CA, USA) is a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer.

3,250,000 Imugene (Australia) is a clinical stage immuno-oncology company developing a range of new treatments that seek to activate the immune system of cancer patients to identify and eradicate tumors.

3,000,000 BioVie Inc. (MA, USA) is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders (Long COVID, AD and PD) and advanced liver disease.

3,000,000 Aptevo Therapeutics (WA, USA) is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.

2,500,000 Theriva Biologics (MD, USA) is a biotechnology company developing biologics for the prevention and treatment of serious infectious diseases.

1,610,000 NurExone Biologic (Israel) is developing a biological exosome based technology drug platform to treat damage in the Central Nerve System.

1,260,000 AIM ImmunoTech (FL, USA) is an immuno-pharmaceutical company that focuses on developing therapeutics that treat cancer and immunodeficiency disorders.

2,000,000,000 Labcorp (NC, USA) is a global leader of laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions.

1,076,000,000 Perrigo (Ireland) is a pharmaceutical and consumer goods company that produces a variety of over-the-counter and generic prescription pharmaceuticals.

850,000,000 Jazz Pharmaceuticals (CA, USA) is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments.

500,000,000 Illumina (CA, USA) is a global genomics and human health leader innovating the future of precision health. They develop DNA sequencing and array-based life sciences technologies to enable boundless research discovery and personalized health.

50,000,000 Poxel?(France) is a research integrated pharmaceutical company that develops products for metabolic diseases.

50,000,000 Mesoblast (Australia) is a medicine company that develops biologic products for the broad field of regenerative medicine.

13,000,000 INmune Bio (CA, USA) is developing therapies that harness the patient's immune system to treat cancer.

4,545,000 Alpha Cognition (Canada) specializes in developing treatments for underserved neurodegenerative diseases.

742,306 ZYUS (Canada) is a biopharmaceutical company that offers patients cannabinoid and other phyto-therapeutic medical solutions.

50,000,000 Mirai Bio (MA, USA) is a Flagship-backed, privately held biotechnology company on a mission to transform the current approach to information molecule therapeutics to unlock their full therapeutic potential.

29,000,000 CPTx (Germany) develops single-stranded DNA products to neutralize viruses and address infectious diseases.

10,397,849 Cartherics (Australia) works to create precisely-defined immunotherapy treatments to combat a variety of cancers. They take a multi-platform approach combining the best components of immune defences utilising gene editing and CAR technology.

6,000,000 BioVersys AG (Switzerland) is a privately-owned clinical stage pharmaceutical company focusing on research and development of small molecules acting on novel bacterial targets with applications in antimicrobial resistance (AMR) and targeted microbiome modulation.

3,259,537 ILC Therapeutics (ILCT) (United Kingdom) is a specialist developer of hybrid interferons, a new engineered drug class with improved therapeutic profiles, with an initial focus on virology and dermatology.

Up to $1 billion! (In a hallmark multi-year agreement with Eli Lilly and Company) HAYA Therapeutics (Switzerland) is a precision medicines company developing RNA-guided programmable therapeutics targeting the regulatory genome for serious health conditions including cardiovascular disease and cancer.

Unknown GenEditBio (China) is a biotech company that specializes in providing curative gene editing based solutions for genetic diseases.